CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.76 Cr | ₹3.91 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹3.76 Cr |
| Mar2025 | ₹3.91 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.76 Cr | -3.73 | |
| Mar2025 | ₹3.91 Cr | -72.67 | |
| Mar2024 | ₹14 Cr | 0.00 | |
| Mar2023 | ₹14 Cr | 7.43 | |
| Mar2022 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,032.1 Cr | 2.8% | -2.9% | -26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 2.8% |
-2.9% |
-26% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses